Literature DB >> 17038805

Nuclear accumulation and activation of nuclear factor kappaB after split-dose irradiation in LS174T cells.

Yong Liu1, Takehisa Nakahara, Junji Miyakoshi, Dong-Liang Hu, Akio Nakane, Yoshinao Abe.   

Abstract

Although radiation-induced gene expression has been extensively studied, most of the studies to date have focused on that after single-dose irradiation. As split-dose irradiation, rather than single-dose irradiation, is usual in clinical situations, we investigated the effects of split-dose irradiation on nuclear factor kappaB (NF-kappaB) in the human rectum carcinoma cell line, LS174T. After either single- or split-dose irradiation with a different interval, nuclear localization of NF-kappaB was examined by Western blot and immunofluorescence and its DNA-binding activity was measured by ELISA-based assay. Irradiation-induced NF-kappaB nuclear accumulation and DNA binding activity increased in a dose-dependent manner. The peak of NF-kappaB nuclear accumulation and DNA binding activity was seen 2 to 6 hours after a single dose of 4 Gy irradiation and returned to control levels after 12 hours. In split-dose irradiation, NF-kappaB activity was similar after the first and second doses of 4 Gy irradiation separated by 12 hours. In addition, NF-kappaB activity was decreased by lengthening the interval between irradiation. The cell survival, which was assessed by colony formation assay, showed inverse correlation to this: the surviving fraction was higher after split-dose irradiation than after single-dose irradiation of the same total dose and it increased as the interval between irradiation was lengthened. Thus the present results showed a correlation between NF-kappaB activation and the repair of sublethal damage in split-dose irradiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038805     DOI: 10.1269/jrr.0615

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  2 in total

1.  Suppressive effects of liquid crystal compounds on the growth of the A549 human lung cancer cell line.

Authors:  Yuuka Takahashi; Masaharu Hazawa; Kenji Takahashi; Ayumi Nishizawa; Atsushi Yoshizawa; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2010-03-17       Impact factor: 3.850

2.  Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth.

Authors:  Masaharu Hazawa; Koji Wada; Kenji Takahashi; Takao Mori; Norio Kawahara; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2008-06-13       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.